USA - Washington

Responding to the interests of a board member, WSLCB staff planned to host a focus group on “high THC” cannabis products - though participation was constrained to industry “networks.”

Legislative ideas for 2025, lengthy cannabis label approvals, updates from CANNRA, traceability, and a reminder about canopy were all brought up by staff or board members.

Respecting Juneteenth, WSLCB members rescheduled their board meeting to Tuesday and would incidentally consider three rulemaking petitions from social equity applicants.

Three presenters talked about health issues related to semi-synthetic cannabinoids, their marketing and availability, followed by possible actions and approaches to lobbying on the topic.

Cannabis and prevention researchers across Washington planned to convene quarterly confabs before WSLCB staff leadership were scheduled to share monthly public updates.

Staff claimed several rulemaking projects and petitions would be advanced in June and July, no one spoke at a public hearing, and members of the public voiced complaints.

State interest in better cannabis education for budtenders and consumers came up when officials briefed board members on a survey conducted between 2023 and 2024.

As WSLCB staff worked to make progress on medical cannabis rulemaking, regulators from across the country would convene in Minneapolis to engage with “External Stakeholders.”

The work group discussed two questions: was it possible to define “high THC” products, and were there gaps in requirements on cannabis product stability?

Following Memorial Day remembrance, only the Health Care Authority Division of Behavioral Health and Recovery planned to convene their monthly meeting to update service providers.